146
Participants
Start Date
July 31, 2009
Primary Completion Date
May 31, 2014
Study Completion Date
December 31, 2016
Lovastatin ™
Lovastatin starting at 20mg for 2 weeks, increasing to 40mg for 14 weeks. Total duration of trial is 16 weeks.
placebo
Starting at 20mg for 2 weeks, then increasing to 40mg for 14 additional weeks for a total duration of treatment of 16 weeks.
The Children's Hospital at Westmead, Westmead
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
NIH, Bethesda
The University of Alabama at Birmingham, Birmingham
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Chicago, Chicago
Washington University - St. Louis, St Louis
Childrens Medical Center - Univ. of Texas SW Medical Center, Dallas
University of Utah, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
Children' Hospital Boston, Boston
Collaborators (1)
Boston Children's Hospital
OTHER
Children's Hospital of Philadelphia
OTHER
Children's National Research Institute
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
National Cancer Institute (NCI)
NIH
University of Chicago
OTHER
University of Utah
OTHER
Washington University School of Medicine
OTHER
Sydney Children's Hospitals Network
OTHER
University of Texas Southwestern Medical Center
OTHER
University of Alabama at Birmingham
OTHER